The global ocular implant market size was valued at USD 10.24 billion in 2016 and is expected to gain momentum at a CAGR of 6.7% during the forecast period. Eye problems such as glaucoma, scleritis, and Age-Related Macular Degeneration (AMD) are increasing interest in ocular implant. The reason for "dry eye" and diabetic retinopathy can be explained by a sedentary lifestyle, which causes diabetes, and eye strain from prolonged work on the PC.
The ocular implant market is characterized based on items: intraocular focal points, corneal inserts, orbital inserts, glaucoma inserts, visual prosthesis, and others. The glaucoma inserts section held the biggest piece of the pie in 2016 and is relied upon to keep up its predominance over the estimated time frame. Intraocular focal points are required to be the quickest developing fragment.
They have acquired high prevalence because they were used all-inclusively for presbyopia, partial blindness, and farsightedness. For these fragments to show successful growth within the estimated timeline, they must show promising development. The disease of glaucoma is one of the leading causes of blindness worldwide. According to data provided by the Glaucoma Research Foundation, about 3.0 million Americans were affected by Glaucoma in 2016. With the growing incidence of glaucoma, the demand for glaucoma inserts is expected to increase, therefore energizing business sector development... Read more